2022 Q1 Form 10-Q Financial Statement

#000156459022017843 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $66.05M $46.66M
YoY Change 41.56% 40.65%
Cost Of Revenue $17.10M $9.250M
YoY Change 84.9% 23.66%
Gross Profit $48.95M $37.41M
YoY Change 30.84% 45.6%
Gross Profit Margin 74.11% 80.18%
Selling, General & Admin $48.49M $32.42M
YoY Change 49.57% 45.84%
% of Gross Profit 99.06% 86.65%
Research & Development $20.94M $13.54M
YoY Change 54.74% 23.94%
% of Gross Profit 42.79% 36.18%
Depreciation & Amortization $2.826M $700.0K
YoY Change 303.71% -22.22%
% of Gross Profit 5.77% 1.87%
Operating Expenses $85.13M $45.95M
YoY Change 85.25% 38.62%
Operating Profit -$36.18M -$8.542M
YoY Change 323.54% 14.58%
Interest Expense -$587.0K $10.00K
YoY Change -5970.0% -98.69%
% of Operating Profit
Other Income/Expense, Net -$156.0K -$14.00K
YoY Change 1014.29% -93.1%
Pretax Income -$36.92M -$8.544M
YoY Change 332.14% 113.28%
Income Tax $115.0K $0.00
% Of Pretax Income
Net Earnings -$37.04M -$8.544M
YoY Change 333.49% 112.38%
Net Earnings / Revenue -56.07% -18.31%
Basic Earnings Per Share -$0.51
Diluted Earnings Per Share -$511.0K -$122.4K
COMMON SHARES
Basic Shares Outstanding 72.47M 68.53M
Diluted Shares Outstanding 72.48M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $376.1M $208.0M
YoY Change 80.82% 530.3%
Cash & Equivalents $250.9M $189.6M
Short-Term Investments $125.2M $18.40M
Other Short-Term Assets $16.14M $11.30M
YoY Change 42.81% 18.95%
Inventory
Prepaid Expenses
Receivables $41.00M $26.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $433.2M $245.4M
YoY Change 76.55% 318.77%
LONG-TERM ASSETS
Property, Plant & Equipment $7.980M $18.10M
YoY Change -55.91% -14.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.710M $5.400M
YoY Change 24.26% 145.45%
Total Long-Term Assets $101.8M $23.40M
YoY Change 334.91% 0.0%
TOTAL ASSETS
Total Short-Term Assets $433.2M $245.4M
Total Long-Term Assets $101.8M $23.40M
Total Assets $535.0M $268.8M
YoY Change 99.04% 227.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.924M $4.700M
YoY Change 68.6% -21.67%
Accrued Expenses $40.62M $18.20M
YoY Change 123.18% 61.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.81M $40.10M
YoY Change 61.61% 21.15%
LONG-TERM LIABILITIES
Long-Term Debt $336.0M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $24.30M $13.40M
YoY Change 81.37% -14.65%
Total Long-Term Liabilities $336.0M $13.40M
YoY Change 2407.65% -84.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.81M $40.10M
Total Long-Term Liabilities $336.0M $13.40M
Total Liabilities $425.1M $53.50M
YoY Change 694.64% -54.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $109.9M $215.3M
YoY Change
Total Liabilities & Shareholders Equity $535.0M $268.8M
YoY Change 99.04% 227.8%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$37.04M -$8.544M
YoY Change 333.49% 112.38%
Depreciation, Depletion And Amortization $2.826M $700.0K
YoY Change 303.71% -22.22%
Cash From Operating Activities -$21.99M -$12.76M
YoY Change 72.32% 27.71%
INVESTING ACTIVITIES
Capital Expenditures -$1.340M -$480.0K
YoY Change 179.17% -20.0%
Acquisitions
YoY Change
Other Investing Activities -$23.47M -$18.37M
YoY Change 27.78%
Cash From Investing Activities -$24.81M -$18.85M
YoY Change 31.61% 3058.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 184.0K 1.741M
YoY Change -89.43% -95.1%
NET CHANGE
Cash From Operating Activities -21.99M -12.76M
Cash From Investing Activities -24.81M -18.85M
Cash From Financing Activities 184.0K 1.741M
Net Change In Cash -46.61M -29.87M
YoY Change 56.05% -219.67%
FREE CASH FLOW
Cash From Operating Activities -$21.99M -$12.76M
Capital Expenditures -$1.340M -$480.0K
Free Cash Flow -$20.65M -$12.28M
YoY Change 68.15% 30.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 bigc First Contingent Compensation Arrangement Payments Over Service Period
FirstContingentCompensationArrangementPaymentsOverServicePeriod
P12M
CY2022Q1 bigc First Contingent Compensation Arrangement Payments Over Service Period
FirstContingentCompensationArrangementPaymentsOverServicePeriod
P12M
CY2022Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-28
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1313000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
726000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2502000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3899000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
806000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
17103000
CY2021Q1 us-gaap Gross Profit
GrossProfit
37410000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12660000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2037000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
85126000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-36179000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8542000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-156000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36922000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8544000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-37037000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8544000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72476000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69792000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-613000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37650000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8544000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
216759000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1952000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5171000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
215338000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
138288000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
277000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-613000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
109877000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-37037000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8544000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2826000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
706000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
488000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8962000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5171000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18854000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
184000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1741000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1741000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190736000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46614000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29871000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
298704000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
220607000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252090000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
96000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250934000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
582000
CY2022Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
658000
CY2021Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
796000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-287000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1130000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190736000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
189578000
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1156000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1158000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252090000
CY2022Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
5702000
CY2021Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
-6399000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14000
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1989000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21985000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12758000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32473000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18374000
CY2022Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1340000
CY2021Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
480000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9000000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24813000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
472000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
32000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
13100000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates, judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition; the amortization period for deferred commissions; the </p> <p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of significant</span><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> accounting policies (continued)</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance for credit losses; a determination of the deferred tax asset valuation allowance and the valuation of our common stock used to determine stock-based compensation expense prior to our IPO. Because of the use of estimates inherent in the financial reporting process and given the additional or unforeseen effects from the COVID-19 pandemic, actual results could differ from those estimates, and such differences could be material to our consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19, declared a global pandemic by the World Health Organization on March 11, 2020, has caused disruption to the economies and communities of the United States and our target international markets. In the interest of public health, many governments closed physical stores and places of business deemed non-essential. This precipitated a significant shift in shopping behavior from offline to online. Our business has benefited from this shift, both in accelerated sales growth for our existing customers’ stores, and in our sales of new store subscriptions to customers. Nevertheless, we do not have certainty that those trends will continue; the COVID-19 pandemic and the uncertainty it has created in the global economy could materially adversely affect our business, financial condition, and results of operations.</p>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66050000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46660000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7980000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7429000
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
14000000.0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3867000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1313000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
637000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4543000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12700000
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0.0
CY2022Q1 bigc Business Combination Acquisition Related Spend
BusinessCombinationAcquisitionRelatedSpend
300000
CY2022Q1 bigc Business Combination Compensation Expense Related To Contingent Compensation
BusinessCombinationCompensationExpenseRelatedToContingentCompensation
12400000
CY2022Q1 bigc Second Contingent Compensation Arrangement Payments Over Service Period
SecondContingentCompensationArrangementPaymentsOverServicePeriod
P24M
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66050000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46660000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7200000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
153500000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize approximately 50% of the remaining performance obligations as revenue in the following 12-month period, and the remaining balance in the periods thereafter.
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 bigc Amortization Of Deferred Sales Commissions Estimated Period
AmortizationOfDeferredSalesCommissionsEstimatedPeriod
P3Y
CY2022Q1 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2021 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2022Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
1600000
CY2021Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
1500000
CY2022Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1100000
CY2021Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
700000
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
345538000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
364994000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5384000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32995000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38379000
CY2021Q3 bigc Business Combinations Existing Products And Financial Milestones
BusinessCombinationsExistingProductsAndFinancialMilestones
65000000.0
CY2022Q1 bigc Second Contingent Compensation Arrangement Payments Over Service Period
SecondContingentCompensationArrangementPaymentsOverServicePeriod
P24M
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0.0
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38379000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3347000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35032000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5968000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7958000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7823000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6134000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3395000
CY2022Q1 bigc Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1717000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32995000
CY2022Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2022Q1 bigc Lease Operating Lease Expiration Year
LeaseOperatingLeaseExpirationYear
2028
CY2022Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
1400000
CY2021Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
900000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1326000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
972000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0541
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0546
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2757000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3258000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2985000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2775000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2528000
CY2022Q1 bigc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2852000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17155000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2273000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14882000
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
813000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
679000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10795000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17315000
CY2022Q1 bigc Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
22559000
CY2021Q4 bigc Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
14309000
CY2022Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3043000
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3951000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37210000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36254000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345000000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345000000
CY2022Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
8975000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
9463000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
336025000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
335537000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
876584
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.25
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8962000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5171000
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0031
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
396000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17955000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9359000

Files In Submission

Name View Source Status
0001564590-22-017843-index-headers.html Edgar Link pending
0001564590-22-017843-index.html Edgar Link pending
0001564590-22-017843.txt Edgar Link pending
0001564590-22-017843-xbrl.zip Edgar Link pending
bigc-10q_20220331.htm Edgar Link pending
bigc-10q_20220331_htm.xml Edgar Link completed
bigc-20220331.xsd Edgar Link pending
bigc-20220331_cal.xml Edgar Link unprocessable
bigc-20220331_def.xml Edgar Link unprocessable
bigc-20220331_lab.xml Edgar Link unprocessable
bigc-20220331_pre.xml Edgar Link unprocessable
bigc-ex102_63.htm Edgar Link pending
bigc-ex103_64.htm Edgar Link pending
bigc-ex104_65.htm Edgar Link pending
bigc-ex105_66.htm Edgar Link pending
bigc-ex106_67.htm Edgar Link pending
bigc-ex107_68.htm Edgar Link pending
bigc-ex311_8.htm Edgar Link pending
bigc-ex312_6.htm Edgar Link pending
bigc-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gjcgelzbzntc000001.jpg Edgar Link pending
glyw35t4hegh000001.jpg Edgar Link pending
gmr3sg2zxyds000001.jpg Edgar Link pending
grupbny3bk3c000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending